SOPHiA GENETICS (SOPH) Long-Term Deferred Tax (2020 - 2025)
SOPHiA GENETICS's Long-Term Deferred Tax history spans 6 years, with the latest figure at $1.8 million for Q4 2025.
- On a quarterly basis, Long-Term Deferred Tax rose 3.62% to $1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 3.62% increase, with the full-year FY2025 number at $1.8 million, up 3.62% from a year prior.
- Long-Term Deferred Tax hit $1.8 million in Q4 2025 for SOPHiA GENETICS, up from $1.7 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for SOPH hit a ceiling of $2.0 million in Q2 2021 and a floor of $1.6 million in Q3 2022.
- Historically, Long-Term Deferred Tax has averaged $1.8 million across 5 years, with a median of $1.8 million in 2024.
- Biggest five-year swings in Long-Term Deferred Tax: dropped 18.77% in 2022 and later grew 23.81% in 2023.
- Tracing SOPH's Long-Term Deferred Tax over 5 years: stood at $2.0 million in 2021, then dropped by 2.51% to $1.9 million in 2022, then decreased by 11.34% to $1.7 million in 2023, then grew by 2.73% to $1.8 million in 2024, then rose by 3.62% to $1.8 million in 2025.
- Business Quant data shows Long-Term Deferred Tax for SOPH at $1.8 million in Q4 2025, $1.7 million in Q3 2025, and $1.8 million in Q2 2025.